Volume 86, Issue 1 pp. 76-81
Research Article

SK&F 97426-A: A novel bile acid sequestrant with higher affinities and slower dissociation rates for bile acids in vitro than cholestyramine

G. Martin Benson

Corresponding Author

G. Martin Benson

SmithKline Beecham Pharmaceuticals, The Frythe, Welwyn, Herts, U.K. AL6 9AR.

SmithKline Beecham Pharmaceuticals, The Frythe, Welwyn, Herts, U.K. AL6 9AR.Search for more papers by this author
David R. Alston

David R. Alston

British Petroleum, Hull, U.K.

Search for more papers by this author
Deirdre M. B. Hickey

Deirdre M. B. Hickey

SmithKline Beecham Pharmaceuticals, The Frythe, Welwyn, Herts, U.K. AL6 9AR.

Search for more papers by this author
Albert A. Jaxa-Chamiec

Albert A. Jaxa-Chamiec

Glaxo Wellcome, Stevenage, Herts, U.K.

Search for more papers by this author
Caroline M. Whittaker

Caroline M. Whittaker

SmithKline Beecham Pharmaceuticals, The Frythe, Welwyn, Herts, U.K. AL6 9AR.

Search for more papers by this author
Claire Haynes

Claire Haynes

Roche Products Ltd, Welwyn Garden City, Herts, U.K.

Search for more papers by this author
Alison Glen

Alison Glen

SmithKline Beecham Pharmaceuticals, The Frythe, Welwyn, Herts, U.K. AL6 9AR.

Search for more papers by this author
Stephen Blanchard

Stephen Blanchard

SmithKline Beecham Pharmaceuticals, The Frythe, Welwyn, Herts, U.K. AL6 9AR.

Search for more papers by this author
Susan R. Cresswell

Susan R. Cresswell

Pharmacia, Belgium.

Search for more papers by this author
Keith E. Suckling

Keith E. Suckling

SmithKline Beecham Pharmaceuticals, The Frythe, Welwyn, Herts, U.K. AL6 9AR.

Search for more papers by this author
First published: 12 June 2000
Citations: 15

Abstract

SK&F 97426-A is a novel bile acid sequestrant that is threefold more potent than cholestyramine at increasing bile acid excretion in the hamster. SK&F 97426-A is a quaternary alkylammonium polymethacrylate that was selected for comparison with cholestyramine in vivo because of its superior in vitro bile acid binding properties. Association, dissociation, affinity, and capacity experiments were performed under physiologically relevant conditions with the most abundant bile acids found in human bile. The bile acids came to equilibrium with SK&F 97426-A and cholestyramine within ∼30 min and 6 min, respectively. SK&F 97426-A and cholestyramine had similar capacities for all the bile acids (between 2.5 and 4 mmol/g) and both had similar, very high affinities and slow dissociation rates for the dihydroxy bile acids. However, SK&F 97426-A had much higher affinities for the trihydroxy bile acids glycocholic acid and taurocholic acid than did cholestyramine. Dissociation of glycocholic acid and taurocholic acid from SK&F 97426-A was also much slower (27 and 25%, respectively, dissociated after 60 min) than from cholestyramine (89 and 84%, respectively, dissociated after 60 min). The higher affinities and slower dissociation rates of the trihydroxy bile acids for and from SK&F 97426-A probably account for the increased potency of SK&F 97426-A over cholestyramine in vivo.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.